Sean Scanlan - Oct 24, 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
SVP, Marketing
Signature
/s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan
Stock symbol
TMCI
Transactions as of
Oct 24, 2022
Transactions value $
$0
Form type
4
Date filed
10/26/2022, 06:03 PM
Previous filing
Mar 10, 2022
Next filing
Nov 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Award $0 +3.4K +51.71% $0.00 9.98K Oct 24, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option (Right to Buy) Award $0 +23K $0.00 23K Oct 24, 2022 Common Stock 23K $9.83 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on October 24, 2023 with the last installment on October 24, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.
F2 Includes 9,975 RSUs.
F3 The stock option will vest in equal annual installments over 4 years, commencing on October 24, 2023 with the last installment on October 24, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.